Table 2.
Cox proportional hazards models for overall survival of patients with breast cancer.
| Variables | Univariable | Multivariable | ||
|---|---|---|---|---|
| HR (95% CI) | P value | HR (95% CI) | P value | |
| CD33+ MDSCs | 2.944 (1.254–7.149) | 0.013 | 3.175 (1.327–7.599) | 0.009 |
| PD-1−PD-L1+ B cells | 2.800 (1.141–6.871) | 0.025 | ||
| Age (≥50 years vs. <50 years) | 0.780 (0.337–1.806) | 0.562 | ||
| LN metastasis(Yes vs. No) | 2.442 (0.995–5.995) | 0.051 | 2.620 (1.065–6.447) | 0.036 |
| TNM stage (III + II vs. I) | 3.461 (1.024–11.700) | 0.046 | ||
| ER (positive vs. negative) | 0.428 (0.185–0.988) | 0.047 | ||
| PR (positive vs. negative) | 0.630 (0.272–1.458) | 0.280 | ||
| HER2 (positive vs. negative) | 1.526 (0.652–3.572) | 0.330 | ||